23.41k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|The Fight Against COVID19||+0.25%||-||-||-|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|JNJ||Johnson & Johnson||178.3||+0.16||+0.09%||4:00 p.m. EDT||5.09M||7.56M||469.18B|
|PFE||Pfizer Inc.||52.75||+1.11||+2.15%||4:03 p.m. EDT||21.02M||24.04M||295.97B|
|ABBV||AbbVie Inc.||152.53||-1.40||-0.91%||4:03 p.m. EDT||4.99M||7.24M||269.54B|
|SNY||Sanofi||50.04||-0.14||-0.28%||4:00 p.m. EDT||2.23M||2.48M||124.97B|
|GSK||GSK plc||43.11||-0.19||-0.44%||4:00 p.m. EDT||4.53M||5.67M||110.02B|
|GILD||Gilead Sciences, Inc.||62.73||+0.39||+0.63%||4:00 p.m. EDT||5.89M||7.97M||78.68B|
|REGN||Regeneron Pharmaceuticals, Inc.||594.9||-1.66||-0.28%||4:00 p.m. EDT||528.90k||692.13k||65.35B|
|MRNA||Moderna, Inc.||159.56||+4.02||+2.58%||4:00 p.m. EDT||4.95M||5.90M||63.47B|
|TAK||Takeda Pharmaceutical Company Limited||14.28||+0.12||+0.85%||4:00 p.m. EDT||1.58M||2.60M||44.35B|
|BNTX||BioNTech SE||160.2||-0.83||-0.52%||4:00 p.m. EDT||867.23k||1.27M||38.93B|
|NVAX||Novavax, Inc.||63.54||-0.75||-1.17%||4:00 p.m. EDT||5.87M||6.26M||4.96B|
|VIR||Vir Biotechnology, Inc.||27.3||-0.51||-1.83%||4:00 p.m. EDT||1.06M||1.04M||3.61B|
|INO||Inovio Pharmaceuticals, Inc.||2.06||-0.01||-0.48%||4:00 p.m. EDT||5.34M||6.47M||471.82M|
Yahoo Finance health reporter Anjalee Khemlani outlines the events surrounding the FDA's ban on Juul products and e-cigarettes, as well as Pfizer's Paxlovid COVID-19 treatment pill receiving an Emergency Use Authorization from the FDA.
Yahoo Finance's health care reporter Anjalee Khemlani breaks down the latest health news, including risks from the BA.5 and BA.4 COVID subvariants and giant African snails that have been spotted in Florida.
The semiconductor market is expanding at a compounded annual growth rate (CAGR) of more than 9%, per estimates from Fortune Business Insights. Insight Partners projects the cloud computing business to be even more promising, with its CAGR up around 24%. Analysts at Grand View Research say this sector could grow at a ridiculous CAGR of 104.2% until 2028.